China NMPA Product Recall - Single-use sterile syringes Syringes

Becton Dickinson and company has initiated a voluntary Class II recall of specific models and batches of its disposable sterile syringes, as reported by Becton Medical Devices (Shanghai) Co., Ltd. The National Medical Products Administration (NMPA) published this recall notice on August 10, 2022. The primary issue prompting this recall is the confirmed presence of foreign matter within certain units of the affected sterile syringe products. This contamination raises potential safety concerns for users and necessitates immediate corrective action. Under the NMPA's regulatory framework for medical devices, a Class II recall signifies a situation where the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. As a required action, Becton Dickinson and company is actively withdrawing the identified faulty products from the market. Further details regarding the specific affected product models, specifications, and batch numbers are available in the accompanying "Medical Device Recall Event Report Form" attachment, ensuring that distributors and healthcare providers can identify and manage the recalled stock effectively. This proactive measure aims to mitigate potential risks to patient safety and maintain product integrity.